Journal of Cancer 2017

9 papers
The 2017 edition of the Journal of Cancer focused on molecular diagnostics, prognostic modeling, and the mechanisms of tumor progression across diverse malignancies. Key research directions included the application of radiomics and deep learning for tumor assessment and the use of multivariate modeling to isolate independent clinical prognostic factors. Specific studies investigated the role of Reelin in multiple myeloma cell adhesion, the impact of TET1 expression in endometrial cancer, and the prognostic significance of hMLH1 and hMSH2 deficiency in early gastric cancer. Other work explored network biomarkers for leukemia and the use of urine and plasma biomarkers to predict prostate cancer severity. Notable trends involved the integration of multi-parametric data for robust diagnostics and the development of high negative predictive value models for clinical rule-out. Research also addressed the overdiagnosis paradox in medical imaging and the use of spatial protein mapping for disease prognosis. Prolific contributors to the volume included authors such as Xiao‐Jun Huang, Ying‐Jun Chang, and Yan Zhang. Collectively, the 2017 papers emphasized precision diagnosis through molecular signatures and the identification of quantitative biological proxies for clinical disease severity.

Top Research Directions

The 16 research directions with Journal of Cancer 2017 papers, ranked by paper count, next to 2016. Share is the fraction of the edition’s papers in the direction.

#Direction20172016Share 2017Share 20162016 rank
1Closing the Intermediate Risk Stratification Gap1011.1%0.0%—
2Composite Multi-Marker Diagnostic Panels1011.1%0.0%—
3How Anatomical Location Dictates Tumor Biology and Prognosis1011.1%0.0%—
4Molecular Mechanisms of the Epithelial Mesenchymal Transition1011.1%0.0%—
5Negative Predictive Value Optimization for Clinical Triage1011.1%0.0%—
6Normalizing Biomarkers by Organ Volume and Tissue Composition1011.1%0.0%—
7Overcoming the Specificity Gap in Clinical Biomarkers1011.1%0.0%—
8Overcoming the Structural Undruggability of Transcription Factors1011.1%0.0%—
9Overcoming Tissue Sampling Bias via Quantitative Radiomics1011.1%0.0%—
10Pharmacological Dissection of Intracellular Signaling Pathways1011.1%0.0%—
11Proportional Hazards Modeling for Survival Analysis1011.1%0.0%—
12Resolving Biomarker Inconsistency in Clinical Prognosis1011.1%0.0%—
13Semi-Quantitative Histological Scoring for Biomarker Quantification1011.1%0.0%—
14The Context Dependent Duality of Cancer Signaling1011.1%0.0%—
15Tracking Dynamic Biomarker Trajectories Over Time1011.1%0.0%—
16Uncovering the Molecular Mechanisms of Transcriptional Control1011.1%0.0%—

Download all directions as CSV

Institutions

Institutions credited by Journal of Cancer 2017 papers: a paper credits every institution named in its affiliations, once. 8 institutions share 3 credited papers.

#InstitutionPapersShare20162016 rank
100ey0ed83 133.3%0—
202kqrq831 133.3%0—
304dzvks42 133.3%0—
405vk9vy20 133.3%0—
5NeoGenomics (United States) 133.3%0—
6Peking University 133.3%0—
7Shanghai Jiao Tong University 133.3%0—
8University of California, Irvine 133.3%0—

Download all institutions as CSV

About this data

Papers. Journal of Cancer 2017 lists 9 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2016 use shares, since the edition went from 5 to 9 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 3 of 9 papers (33.3%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-18 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Journal of Cancer 2017”, https://lacuna.tiptreesystems.com/venue/journal-of-cancer/2017.

Top Authors

AuthorPapers
Mark A. Healy1
Masayuki Watanabe1
Shunichi Fukuhara1
Toshifusa Nakajima1
Xun Chen1

Impactful Papers

Papers from Journal of Cancer 2017 that shaped research clusters.

Influential

Papers

Title
A Multi-Center Prospective Study to Validate an Algorithm Using Urine and Plasma Biomarkers for Predicting Gleason ≥3+4 Prostate Cancer on Biopsy
Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in Early Gastric Cancer (EGC)
Increased TET1 Expression in Inflammatory Microenvironment of Hyperinsulinemia Enhances the Response of Endometrial Cancer to Estrogen by Epigenetic Modulation of GPER
Long-term Trends in Primary Sites of Gastric Adenocarcinoma in Japan and the United States
Network Biomarkers Constructed from Gene Expression and Protein-Protein Interaction Data for Accurate Prediction of Leukemia
Reelin promotes adhesion of multiple myeloma cells to bone marrow stromal cells via integrin β1 signaling
Sulforaphane Induced Apoptosis via Promotion of Mitochondrial Fusion and ERK1/2-Mediated 26S Proteasome Degradation of Novel Pro-survival Bim and Upregulation of Bax in Human Non-Small Cell Lung Cance
The Emerging Roles of Forkhead Box (FOX) Proteins in Osteosarcoma
The Prognostic Impact of the Carcinoembryonic Antigen in Ampullary Cancer - A Retrospective Single Center Study